Champions Oncology (CSBR) Other Non Operating Income (2010 - 2026)
Champions Oncology (CSBR) posted Other Non Operating Income of $27000.0 for Q2 2026, down 30.77% on a QoQ basis from $39000.0 in Q1 2026, and down 37.21% year-over-year from $43000.0 in Q2 2025.
Powered by 
Analysis
Champions Oncology (CSBR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Champions Oncology has reported Other Non Operating Income for 17 years, with the latest figure at $27000.0 in Q2 2026.
- On a quarterly basis, Other Non Operating Income fell 37.21% year-over-year to $27000.0 in Q2 2026; TTM through Apr 2026 was $211000.0, a 185.14% increase from a year earlier, with the FY2026 full-year figure at $211000.0, up 189.04% from the prior year.
- Other Non Operating Income was $27000.0 for Q2 2026 at Champions Oncology, down from $39000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $81000.0 in Q2 2024, with the low at -$105000.0 in Q4 2023.
- Average Other Non Operating Income over 5 years is $14166.7, with a median of $16500.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income sank 1066.67% in 2023, then soared 1400.0% in 2025.
- Over 5 years, Other Non Operating Income stood at -$9000.0 in 2022, then tumbled by 1066.67% to -$105000.0 in 2023, then soared by 106.67% to $7000.0 in 2024, then jumped by 900.0% to $70000.0 in 2025, then plunged by 61.43% to $27000.0 in 2026.
- The last three Other Non Operating Income figures came in at $27000.0 (Q2 2026), $39000.0 (Q1 2026), and $70000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 27,000.00 |
| Jan 31, 2026 | 39,000.00 |
| Oct 31, 2025 | 70,000.00 |
| Jul 31, 2025 | 75,000.00 |
| Apr 30, 2025 | 43,000.00 |
| Jan 31, 2025 | 19,000.00 |
| Oct 31, 2024 | 7,000.00 |
| Jul 31, 2024 | 5,000.00 |
| Apr 30, 2024 | 81,000.00 |
| Jan 31, 2024 | 58,000.00 |
| Oct 31, 2023 | -105,000.00 |
| Jul 31, 2023 | 14,000.00 |
| Apr 30, 2023 | -20,000.00 |
| Jan 31, 2023 | 36,000.00 |
| Oct 31, 2022 | -9,000.00 |
| Jul 31, 2022 | -18,000.00 |
| Apr 30, 2022 | -35,000.00 |
| Jan 31, 2022 | -32,000.00 |
| Oct 31, 2021 | 26,000.00 |
| Jul 31, 2021 | 17,000.00 |